163 related articles for article (PubMed ID: 34122079)
1. Pharmacokinetics of Intraperitoneal Vancomycin and Amikacin in Automated Peritoneal Dialysis Patients With Peritonitis.
Falbo Dos Reis P; Barretti P; Marinho L; Balbi AL; Awdishu L; Ponce D
Front Pharmacol; 2021; 12():658014. PubMed ID: 34122079
[No Abstract] [Full Text] [Related]
2. Vancomycin and ciprofloxacin: systemic antibiotic administration for peritoneal dialysis-associated peritonitis.
Goffin E; Herbiet L; Pouthier D; Pochet JM; Lafontaine JJ; Christophe JL; Gigi J; Vandercam B
Perit Dial Int; 2004; 24(5):433-9. PubMed ID: 15490982
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of once daily intra-peritoneal aztreonam and vancomycin in the treatment of CAPD peritonitis.
Brown J; Altmann P; Cunningham J; Shaw E; Marsh F
J Antimicrob Chemother; 1990 Jan; 25(1):141-7. PubMed ID: 2318749
[TBL] [Abstract][Full Text] [Related]
4. Intravenous vancomycin as initial treatment for gram-positive peritonitis in patients on chronic peritoneal dialysis.
Obermiller LE; Tzamaloukas AH; Leymon P; Avasthi PS
Clin Nephrol; 1985 Nov; 24(5):256-60. PubMed ID: 3907908
[TBL] [Abstract][Full Text] [Related]
5. Treatment of gram-positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients.
Bastani B; Freer K; Read D; Bailey S; Sherman RA; Davis M; Engels D; Westervelt FB
Nephron; 1987; 45(4):283-5. PubMed ID: 3587467
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis-Related Peritonitis: A Randomized Controlled Pilot Study.
Xu R; Yang Z; Qu Z; Wang H; Tian X; Johnson DW; Dong J
Am J Kidney Dis; 2017 Jul; 70(1):30-37. PubMed ID: 28027794
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal vancomycin concentrations during peritoneal dialysis-associated peritonitis: correlation with serum levels.
Fish R; Nipah R; Jones C; Finney H; Fan SL
Perit Dial Int; 2012; 32(3):332-8. PubMed ID: 22045102
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intravenous vancomycin in the treatment of gram-positive peritonitis in long-term peritoneal dialysis.
Krothapalli RK; Senekjian HO; Ayus JC
Am J Med; 1983 Aug; 75(2):345-8. PubMed ID: 6881188
[TBL] [Abstract][Full Text] [Related]
9. Serum vancomycin levels predict the short-term adverse outcomes of peritoneal dialysis-associated peritonitis.
Ma Y; Geng Y; Jin L; Wang X; Liang C; Xie L; Lu W; Lv J
Perit Dial Int; 2023 Jan; 43(1):37-44. PubMed ID: 35021905
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.
Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP
Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768
[TBL] [Abstract][Full Text] [Related]
11. Single UK centre experience on the treatment of PD peritonitis--antibiotic levels and outcomes.
Blunden M; Zeitlin D; Ashman N; Fan SL
Nephrol Dial Transplant; 2007 Jun; 22(6):1714-9. PubMed ID: 17369615
[TBL] [Abstract][Full Text] [Related]
12. Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients.
Mulhern JG; Braden GL; O'Shea MH; Madden RL; Lipkowitz GS; Germain MJ
Am J Kidney Dis; 1995 Apr; 25(4):611-5. PubMed ID: 7702059
[TBL] [Abstract][Full Text] [Related]
13. Once weekly intraperitoneal therapy for gram-positive peritonitis.
Morse GD; Nairn DK; Walshe JJ
Am J Kidney Dis; 1987 Oct; 10(4):300-5. PubMed ID: 3661551
[TBL] [Abstract][Full Text] [Related]
14. Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS).
Schaefer F; Klaus G; Müller-Wiefel DE; Mehls O
J Am Soc Nephrol; 1999 Jan; 10(1):136-45. PubMed ID: 9890319
[TBL] [Abstract][Full Text] [Related]
15. Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis.
Wong KM; Chan YH; Cheung CY; Chak WL; Choi KS; Leung SH; Leung J; Chau KF; Tsang DN; Li CS
Am J Kidney Dis; 2001 Jul; 38(1):127-31. PubMed ID: 11431192
[TBL] [Abstract][Full Text] [Related]
16. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
[TBL] [Abstract][Full Text] [Related]
17. Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.
Neal D; Bailie GR
Clin Pharmacokinet; 1990 Jun; 18(6):485-90. PubMed ID: 2354591
[TBL] [Abstract][Full Text] [Related]
18. Predictors of serum vancomycin levels in peritoneal dialysis-associated peritonitis.
Deacon E; Canney M; McCormick B; Brown P; Biyani M; Zimmerman D
Perit Dial Int; 2023 Jan; 43(1):45-52. PubMed ID: 36350011
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the pharmacodynamic profile of commonly used intravenous vancomycin dosing schemes in patients on automated peritoneal dialysis.
Cardone KE; Chen WZ; Grabe DW; Batzold A; Manley HJ; Lodise TP
J Antimicrob Chemother; 2014 Jul; 69(7):1873-6. PubMed ID: 24722842
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin therapy for gram-positive peritonitis in patients on CAPD.
Vargemezis V; Pasadakis P; Thodis H; Coucudis P; Peihaberis P; Jafer H; Jara F; Kartali S
Adv Perit Dial; 1989; 5():128-9. PubMed ID: 2577394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
